Floyd Financial Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$662K Sell
4,662
-697
-13% -$96.3K 0.41% 48
2026
Q2
$647K Sell
5,359
-17
-0.3% -$1.99K 0.42% 49
2026
Q1
$634K Buy
5,376
+37
+0.7% +$4.27K 0.42% 52
2025
Q4
$653K Buy
5,339
+41
+0.8% +$3.85K 0.44% 52
2025
Q3
$454K Buy
5,298
+409
+8% +$33.7K 0.34% 47
2025
Q2
$396K Sell
4,889
-48
-1% -$3.82K 0.37% 40
2025
Q1
$443K Buy
4,937
+450
+10% +$42K 0.4% 46
2024
Q4
$445K Buy
+4,487
New +$463K 0.37% 51

Other funds holding MRK

Floyd Financial Group's MRK Position: Q3 2026 in Review

Floyd Financial Group reduced its Merck (MRK) stake by 13% in Q3 2026, selling an estimated $96.3K and leaving 4,662 shares worth $662K. The position accounts for 0.41% of the portfolio, ranked #48.

Floyd Financial Group first reported a position in MRK in Q4 2024 and has held it in 8 quarters since. 3,520 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Floyd Financial Group held 4,662 shares of Merck worth $662K as of Q3 2026.
  • Floyd Financial Group sold 697 Merck shares in Q3 2026, an estimated $96.3K.
  • Merck made up 0.41% of Floyd Financial Group's portfolio in Q3 2026, its #48 holding.
  • Floyd Financial Group first reported a position in Merck in Q4 2024 and has held it in 8 quarters since.
  • 3,520 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Floyd Financial Group's 13F filing for Q3 2026, filed 28 Oct 2026.